Title: Population Surveys Scopes, Prevalence, Incidence, Health Registries
1Population SurveysScopes, Prevalence, Incidence,
Health Registries
- Ettore Beghi
- Institute for Pharmacological Research Mario
Negri, Milano, Italy
2SCOPE OF POPULATION SURVEYS
- Measure prevalence
- Measure incidence
- Measure mortality
- Identify cases for case-control studies
- Identify exposures for cohort studies
- Study familial aggregation/genetics
- Screen candidates for prevention/early treatment
3ANATOMY OF A POPULATION SURVEY
- Definition of the study population
- Definition of disease
- Case ascertainment (prevalence, incidence and
mortality) - Calculation of epidemiological indexes
- Distribution by time, place person
4DIAGRAM OF THE IDENTIFICATION OF A DISEASE IN THE
GENERAL POPULATION
Kurtzke, 1978
5HOW TO DEFINE A POPULATION
- Geographic boundaries - Residency -
Istituzionalization - Migration - Temporal boundaries - Prevalence period
(point, period, lifetime) - Incidence period
6MEASURES OF DISEASE FREQUENCY
- INCIDENCE Number of individuals in a population
that become ill in a stated period of time - CUMULATIVE INCIDENCE Proportion of a fixed
population that becomes ill in a stated period of
time - PREVALENCE Proportion of a population affected
by a disease at a given point of time - MORTALITY Number of individuals in a population
died for a disease in a stated period of time
7PREVALENCE AND INCIDENCE
Prevalence Incidence x average duration
Incidence
Migrating in
Migrating out
Prevalence
Death
Recovery
8SOURCES OF NEUROLOGICAL DISEASES IN
EPIDEMIOLOGICAL STUDIES
- Hospital records
- Ambulatory records
- Electrophysiological (EMG) records
- General practitioners files
- Disability records
- Lay associations
- Tertiary centers
- Death certificates
- Diagnosis related groups (DRGs)
- Disease registries
9MIGRAINE IS A HETEROGENEOUS AND ILL-DEFINED
CLINICAL CONDITION
- Intensity, duration, frequency and
characteristics of attacks tend to vary in the
general population - In each patient, symptoms may vary with time
- Many individuals may have different types of
headache - Many individuals do not consult their doctor for
headache
10MIGRAINE WITHOUT AURA (IHS, 1988)
- A. At least 5 attacks with criteria B-D
- B. Attacks lasting 4-72 hr (no or poor treatment)
- C. Headache with at least two features -
Unilateral - Pulsating - Moderate
or severe - D. At least one among - Nausea and/or
vomiting - Photophobia and/or phonophobia - E. At least one of the following - Other
disturbances excluded by hx and examination -
Other disturbances excluded by diagnostic
tests - Other disturbances, but migraine attacks
verified
11CHANGE IN THE PREVALENCE OF MIGRAINE WHEN VARYING
THE NUMBER OF IHS DIAGNOSTIC CRITERIA
Merikangas et al, 1990
12EPILEPSY AND EPILEPTIC SEIZURES
- EPILEPSY Clinical condition characterized by
repeated unprovoked seizures - UNPROVOKED SEIZURE Seizure occurring in the
absence of known precipitants it may occur at
the presence of a non-recent CNS injury - ACUTE SYMPTOMATIC SEIZURE Seizure occurring in
close temporal relationship with an acute CNS
insult
13EPILEPSY, ACTIVE IN REMISSIONDefinitions
- ACTIVE EPILEPSY epilepsy currently being treated
or whose most recent seizure has occurred
(usually) within the past two to five years
(Thurman et al, Epilepsia, 2011) - EPILEPSY IN TERMINAL REMISSION absence of
seizures for 2 or 5 years without AEDs
14ACUTE SYMPTOMATIC SEIZURESInterval from
precipitating factor
CNS Insult Timing of occurrence
Stroke, head trauma, cerebral anoxia 1 week
Cerebral infection Positive clinical/laboratory findings
Brain abscess, cerebral tuberculoma During treatment
HIV infection Acute infection/metabolic disturb
Arterovenous malformation Acute hemorrhage
Multiple sclerosis Within 7 days of relapse
Autoimmune diseases Symptoms/signs of activation
Neurodegenerative disorders None identified
Epidemiology Task Force, Epilepsia 2009
15EPIDEMIOLOGICAL INDEXES OF EPILEPSY IN
INDUSTRIALIZED COUNTRIES
- Incidence Epilepsy 29-53 100,000/yr
Epilepsysingle seizures 73-86 Acute sympt
seizures 20-30 Status epilepticus 10-40 - Cumulative incidence 1-3
- Prevalence Active epilepsy 5-8
x1,000 Lifetime 15-50 - Mortality 1-4 x100,000/yr
- SMR 2-3
16DeCarli, Lancet Neurol 2003 215
17PREVALENCE OF COGNITIVE IMPAIRMENT ACCORDING TO
CLINICAL DEFINITION
DeCarli, Lancet Neurol 2003 215
18PROBLEMS REGARDING THE DIAGNOSIS OF POLYNEUROPATHY
- The majority of the available data comes from
clinical series - The diagnosis of polyneuropathy is based on
clinical and elettrophysiological features - Polyneuropathy includes a wide spectrum of
disorders ranging from symptomatic clinical
conditions to subclinical variants - Diagnosis should be confirmed by a neurologist
19Polyneuropathy in the ElderlyPrincipal Symptoms
- Muscle cramps
- Restless legs syndrome
- Burning feet
- Muscle pain
- Problems with handling objects
- Impairment of standing and gait
- Glove and stocking paresthesiae
20POLYNEUROPATHY IN THE ELDERLYValidity of the
screening questions
Monticelli et al, Neuroepidemiology 1993
21 POLYNEUROPATHY IN THE ELDERLYInter-rater
agreement (kappa statistic)
Monticelli et al, Neuroepidemiology 1993
22EL ESCORIAL CRITERIA FOR THE DIAGNOSIS OF ALS
- Based on the topographical location of upper
(UMN) and lower motor neuron (LMN) signs in 4 CNS
regions, progression of these signs, and absence
of other diseases - Degree of diagnostic certainty (definite,
probable, possible, suspected ALS) based on a
different combination of UMN and LMN signs
Brooks, 1994
23EL ESCORIAL CRITERIA FOR THE DIAGNOSIS OF ALS
- DEFINITE ALS - LMN and UMN signs in 3
spinal regions - LMN and UMN signs in the
bulbar region and in 2 spinal regions - PROBABLE ALS - LMN and UMN signs in 2
spinal regions - POSSIBLE ALS - LMN and UMN signs in 1
region - UMN signs in 2 or more regions -
LMN signs rostral to UMN signs - SUSPECTED ALS - LMN signs in 2 or more
regions
Source J Neurol Sci 1994 124 (suppl) 96-107
24DISEASE REGISTRIES
- Lists of diseases (or disease groups) in
well-defined populations - Collection of data on disease burden and
identification of patients cohorts to be
followed for specific purposes - For rare diseases, registries represent a
(re)source for the collection of sizable numbers
of cases for focused studies
25EXPLANATIONS FOR HIGHER AND MORE HOMOGENEOUS
RATES IN EUROPEAN REGISTRIES
- Prospective inception of cases
- Multiple sources
- Fairly complete case ascertainment
- Continuous surveillance
- Use of the same diagnostic criteria
26OBJECTIVES OF A POPULATION-BASED REGISTRY
- Incidence and prevalence of the target condition
- Temporal and geographic trends of the disease
- Full clinical spectrum of the disease
- Clinical and paraclinical markers of the disease
- Practical management and socio-economic
implications of the disease - Data banks for clinical/biological material
27PREREQUISITES FOR THE START OF A REGISTRY
- Definition of the population at risk
- Selection of the best source(s) of cases
- Choice of the correct diagnostic criteria
28SOURCES OF CASES
- Hospital records
- Outpatient records
- Neurophysiology units archives
- General practitioners files
- Disability records
- Lay associations files
- ALS centers
- Death certificates
- Administrative files (hospital discharge
diagnoses)
29THE EURALS CONSORTIUM
- Ireland 5.0M
- Scotland 5.0M
- Lancashire Cumbria 1.8M
- London 2.8M
- Italy (all) 8.0M
- Belgrade 2.0M
- Madrid 1.0M
- Limousin 0.7M
- Germany ?
- Russia ?
- Israel ?
- Total gt25M
30(No Transcript)
31(No Transcript)
32PRACTICAL RECOMMENDATIONS TO START A
POPULATION-BASED REGISTRY
- Select a well-defined geographic area
- Identify one or more accessible sources
- Use valid and reliable diagnostic criteria
- Set a network of specialists able to trace all
cases residing in the area - Select a number of core variables to verify the
correctness of the diagnosis and define the
general profile of the disease - Start specific studies only after preparing
ad-hoc protocols and case collection forms